Xtrackers SLI UCITS ETF 1D EUR is a equity ETF from Xtrackers tracking the SLI index through physical replication. Domiciled in Luxembourg and launched in 2008, the fund manages about 516 M € and charges a TER of 0.26% — 26 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
Xtrackers SLI UCITS ETF 1D EUR competes with 1 other products on the same index (SLI): it ranks 2nd by fund size and 1st by ongoing cost, with a TER of 0.26% against a group median of 0.39%. It has been listed since 2008, 18 years of track record.
On a €10,000 investment the TER costs 26 € a year, and no product in the group costs less.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 61.4% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Luxembourg, which determines the tax treatment of income received by the fund and the supervisory authority.
| UBS Group AG | 9.1% |
| Nestle S.A. | 8.9% |
| Novartis AG | 8.9% |
| Roche Holding AG | 8.7% |
| ABB Ltd | 4.6% |
| Compagnie Financière Richemont SA | 4.6% |
| Zurich Insurance Group AG | 4.6% |
| Holcim AG | 4.0% |
| Swiss Re AG | 4.0% |
| Lonza Group AG | 4.0% |
| XETRA | DXS0 | EUR |
| Francoforte | DXS0 | EUR |
| SIX Swiss Exchange | XSLI | CHF |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.